Cristina Mayor-Ruiz obtained her PhD under the supervision of Óscar Fernández-Capetillo at the CNIO (Madrid) in 2017, exploring mechanisms of resistance to genotoxic and targeted anticancer therapies. In 2018, she joined the group of Georg Winter at CeMM (Vienna) supported by and EMBO and a Marie Curie postdoctoral fellowships. Her research interests focused on different aspects of targeted protein degradation: cellular effectors, resistance mechanisms, identification of new molecular glues, etc. In addition, she developed chemical-biology approaches to identify and disrupt transcriptional effectors of mutant RAS proteins. She will start her own group at the IRB Barcelona at the end of 2020, where she plans to explore the multifaceted subtleties of targeted protein degradation to ultimately control protein activity in cancer.